The cystic fibrosis treatment leader exceeded revenue expectations, but missed slightly on earnings per share.

Operator Good day, and welcome to the Vertex Pharmaceuticals fourth quarter 2024 earnings call. All participants will be in a ...

Q4 2024 Earnings Call Transcript February 10, 2025 Vertex Pharmaceuticals Incorporated misses on earnings expectations. Reported EPS is $3.98 EPS, expectations were $4.02. Operator: Good day, and ...

Vertex’s move for Alpine marks a turnaround in the fortunes ... and recently added to its portfolio with a therapy for blood disorders sickle cell disease (SCD) and transfusion-dependent beta ...

Vertex Pharmaceuticals (VRTX) stock has performed strongly since the turn of the year, gaining 14.6% and vastly outperforming the healthcare ...

The Alpine Swift is characterised by its large size among swifts, with a sleek, streamlined body. Its upperparts are a uniform dark brown, contrasting sharply with a white belly and throat, separated ...

Alpine executive advisor Flavio Briatore may have accidentally leaked, albeit blurry, pictures of the team’s 2025 car, the A525, and its pink-and-blue livery. The Italian posted a video on his ...

For those living with sickle cell disease, daily life is a series of obstacles that demand unwavering strength. The condition is relentless, marked by excruciating pain crises, organ damage ...

Brain Age Modeling and Cognitive Outcomes in Young Adults With and Without Sickle Cell Anemia. JAMA Network Open , 2025; 8 (1): e2453669 DOI: 10.1001/jamanetworkopen.2024.53669 Cite This Page : ...

Today, the Brooklyn band are following that up with another single called “Sickle Walk,” along with the news that their new album 45 Pounds is out in March. YHWH Nailgun’s Bandcamp page desc ...